Rifasutenizol
- Generic Name
- Rifasutenizol
Drug-Drug Interactions Between TNP-2198 and Midazolam, Clarithromycin
Phase 1
Completed
- Conditions
- Helicobacter Pylori Infection
- Interventions
- First Posted Date
- 2024-08-13
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- TenNor Therapeutics Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT06551623
- Locations
- 🇨🇳
The First Hospital of Jinlin University, Changchun, Jilin, China
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effect of TNP-2198 Capsules After Single Oral Dose in Healthy Participants
Phase 1
Completed
- Conditions
- Helicobacter Pylori Infection
- Interventions
- Drug: TNP-2198 Placebo
- First Posted Date
- 2023-10-13
- Last Posted Date
- 2023-10-13
- Lead Sponsor
- TenNor Therapeutics (Suzhou) Limited
- Target Recruit Count
- 78
- Registration Number
- NCT06081699
- Locations
- 🇨🇳
The First Hospital of Jilin University, Changchun, Jilin, China
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of TNP-2198 Capsules in Asymptomatic Participants With Helicobacter Pylori Infection
Phase 1
Completed
- Conditions
- Helicobacter Pylori Infection
- Interventions
- Drug: TNP-2198 Placebo
- First Posted Date
- 2023-10-13
- Last Posted Date
- 2023-10-13
- Lead Sponsor
- TenNor Therapeutics (Suzhou) Limited
- Target Recruit Count
- 48
- Registration Number
- NCT06081712
- Locations
- 🇨🇳
The First Hospital of Jilin University, Changchun, Jilin, China
Efficacy and Safety After Multiple Doses of TNP-2198 Capsules, Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin Capsules in Helicobacter Pylori Infected-positive Participants
Phase 2
Completed
- Conditions
- Helicobacter Pylori Infection
- Interventions
- First Posted Date
- 2023-10-11
- Last Posted Date
- 2023-12-12
- Lead Sponsor
- TenNor Therapeutics (Suzhou) Limited
- Target Recruit Count
- 80
- Registration Number
- NCT06076694
- Locations
- 🇨🇳
The First Hospital of Jilin University, Chang chun, Jilin, China
A Study to Evaluate Preliminary Helicobacter Pylori Eradication After Multiple Doses of TNP-2198 Capsules Combined With Rabeprazole Sodium Enteric-coated Tablets, or Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin Capsules
Phase 1
Completed
- Conditions
- Helicobacter Pylori Infection
- Interventions
- First Posted Date
- 2023-10-11
- Last Posted Date
- 2023-11-22
- Lead Sponsor
- TenNor Therapeutics (Suzhou) Limited
- Target Recruit Count
- 40
- Registration Number
- NCT06076681
- Locations
- 🇨🇳
The First Hospital of Jilin University, Chang chun, Jilin, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath